Submission Number: 00003 

Received: 10/7/2011 5:10:01 PM
Commenter:  Temperis
Organization: 
State: Outside the United States
Agency: Federal Trade Commission
Initiative: Proposed Consent Agreement In the Matter of Teva Pharmaceutical Industries Ltd. and Cephalon, Inc., File No. 111-0166
Attachments: No Attachments
Submission Text
Thank you for providing us the opportunity to take part in public debate. I am wondering why it is required Teva to sell its rights and assets to Par Pharmaceuticals Inc., a generic drug manufacturer based in New Jersey, and not to another company in or out US (EU for instance). Which are the crucial criteria? Yours faithfully, D. A. Temperis Attorney at Law Athens, Greece